Cargando…

Metabolic Syndrome and Serum Liver Enzymes Level at Patients with Type 2 Diabetes Mellitus

OBJECTIVES: The aim of this study was to evaluate liver function in patients with type 2 diabetes mellitus (T2DM) with and without metabolic syndrome (MS) by determining serum levels of gamma glutamyltransferase (GGT), alanine aminotransferase (ALT) and aspartate aminotransferase (AST). We also inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Music, Miralem, Dervisevic, Amela, Pepic, Esad, Lepara, Orhan, Fajkic, Almir, Ascic-Buturovic, Belma, Tuna, Enes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AVICENA, d.o.o., Sarajevo 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610622/
https://www.ncbi.nlm.nih.gov/pubmed/26543313
http://dx.doi.org/10.5455/medarh.2015.69.251-255
_version_ 1782395978657038336
author Music, Miralem
Dervisevic, Amela
Pepic, Esad
Lepara, Orhan
Fajkic, Almir
Ascic-Buturovic, Belma
Tuna, Enes
author_facet Music, Miralem
Dervisevic, Amela
Pepic, Esad
Lepara, Orhan
Fajkic, Almir
Ascic-Buturovic, Belma
Tuna, Enes
author_sort Music, Miralem
collection PubMed
description OBJECTIVES: The aim of this study was to evaluate liver function in patients with type 2 diabetes mellitus (T2DM) with and without metabolic syndrome (MS) by determining serum levels of gamma glutamyltransferase (GGT), alanine aminotransferase (ALT) and aspartate aminotransferase (AST). We also investigated correlation between levels of liver enzymes and some components of MS in both groups of patients. METHODS: This cross-sectional study included 96 patients (age 47–83 years) with T2DM. All patients were divided according to the criteria of the National Cholesterol Education Program (NCEP) in two groups: 50 patients with T2 DM and MS (T2DM-MS) and 46 patients with T2DM without MS (T2DM-Non MS). The analysis included blood pressure monitoring and laboratory tests: fasting blood glucose (FBG), total lipoprotein cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), triglyceride (TG), fibrinogen and liver enzymes: GGT, ALT and AST. T2DM-MS group included patients which had FBG ≥ 6,1 mmol/L, TG ≥ 1,7 mmol/L and blood pressure ≥ 130/85 mm Hg. RESULTS: T2DM-MS patients had significant higher values of systolic blood pressure, diastolic blood pressure and medium arterial pressure compared to T2DM-Non MS patients. Serum levels of TC, TG, LDL-C, VLDL-C and FBG were significantly higher in the T2DM-MS group compared to the T2DM-Non MS group. Serum fibrinogen level and GGT level were significantly higher in patients with T2DM-MS compared to the serum fibrinogen level and GGT level in T2DM-Non MS patients. Mean serum AST and ALT level were higher, but not significantly, in patients with T2DM and MS compared to the patients with T2DM without MS. Significant negative correlations were observed between TC and AST (r= -0,28, p<0,05), as well as between TC and ALT level (r= -0,29, p<0,05) in T2DM-MS group of patients. CONCLUSION: These results suggest that patients with T2DM and MS have markedly elevated liver enzymes. T2DM and MS probably play a role in increasing the risk of liver injury.
format Online
Article
Text
id pubmed-4610622
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher AVICENA, d.o.o., Sarajevo
record_format MEDLINE/PubMed
spelling pubmed-46106222015-11-05 Metabolic Syndrome and Serum Liver Enzymes Level at Patients with Type 2 Diabetes Mellitus Music, Miralem Dervisevic, Amela Pepic, Esad Lepara, Orhan Fajkic, Almir Ascic-Buturovic, Belma Tuna, Enes Med Arch Original Paper OBJECTIVES: The aim of this study was to evaluate liver function in patients with type 2 diabetes mellitus (T2DM) with and without metabolic syndrome (MS) by determining serum levels of gamma glutamyltransferase (GGT), alanine aminotransferase (ALT) and aspartate aminotransferase (AST). We also investigated correlation between levels of liver enzymes and some components of MS in both groups of patients. METHODS: This cross-sectional study included 96 patients (age 47–83 years) with T2DM. All patients were divided according to the criteria of the National Cholesterol Education Program (NCEP) in two groups: 50 patients with T2 DM and MS (T2DM-MS) and 46 patients with T2DM without MS (T2DM-Non MS). The analysis included blood pressure monitoring and laboratory tests: fasting blood glucose (FBG), total lipoprotein cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), triglyceride (TG), fibrinogen and liver enzymes: GGT, ALT and AST. T2DM-MS group included patients which had FBG ≥ 6,1 mmol/L, TG ≥ 1,7 mmol/L and blood pressure ≥ 130/85 mm Hg. RESULTS: T2DM-MS patients had significant higher values of systolic blood pressure, diastolic blood pressure and medium arterial pressure compared to T2DM-Non MS patients. Serum levels of TC, TG, LDL-C, VLDL-C and FBG were significantly higher in the T2DM-MS group compared to the T2DM-Non MS group. Serum fibrinogen level and GGT level were significantly higher in patients with T2DM-MS compared to the serum fibrinogen level and GGT level in T2DM-Non MS patients. Mean serum AST and ALT level were higher, but not significantly, in patients with T2DM and MS compared to the patients with T2DM without MS. Significant negative correlations were observed between TC and AST (r= -0,28, p<0,05), as well as between TC and ALT level (r= -0,29, p<0,05) in T2DM-MS group of patients. CONCLUSION: These results suggest that patients with T2DM and MS have markedly elevated liver enzymes. T2DM and MS probably play a role in increasing the risk of liver injury. AVICENA, d.o.o., Sarajevo 2015-08-04 2015-08 /pmc/articles/PMC4610622/ /pubmed/26543313 http://dx.doi.org/10.5455/medarh.2015.69.251-255 Text en Copyright: © 2015 Miralem Music, Amela Dervisevic, Esad Pepic, Orhan Lepara, Almir Fajkic, Belma Ascic-Buturovic, Enes Tuna http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Paper
Music, Miralem
Dervisevic, Amela
Pepic, Esad
Lepara, Orhan
Fajkic, Almir
Ascic-Buturovic, Belma
Tuna, Enes
Metabolic Syndrome and Serum Liver Enzymes Level at Patients with Type 2 Diabetes Mellitus
title Metabolic Syndrome and Serum Liver Enzymes Level at Patients with Type 2 Diabetes Mellitus
title_full Metabolic Syndrome and Serum Liver Enzymes Level at Patients with Type 2 Diabetes Mellitus
title_fullStr Metabolic Syndrome and Serum Liver Enzymes Level at Patients with Type 2 Diabetes Mellitus
title_full_unstemmed Metabolic Syndrome and Serum Liver Enzymes Level at Patients with Type 2 Diabetes Mellitus
title_short Metabolic Syndrome and Serum Liver Enzymes Level at Patients with Type 2 Diabetes Mellitus
title_sort metabolic syndrome and serum liver enzymes level at patients with type 2 diabetes mellitus
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610622/
https://www.ncbi.nlm.nih.gov/pubmed/26543313
http://dx.doi.org/10.5455/medarh.2015.69.251-255
work_keys_str_mv AT musicmiralem metabolicsyndromeandserumliverenzymeslevelatpatientswithtype2diabetesmellitus
AT dervisevicamela metabolicsyndromeandserumliverenzymeslevelatpatientswithtype2diabetesmellitus
AT pepicesad metabolicsyndromeandserumliverenzymeslevelatpatientswithtype2diabetesmellitus
AT leparaorhan metabolicsyndromeandserumliverenzymeslevelatpatientswithtype2diabetesmellitus
AT fajkicalmir metabolicsyndromeandserumliverenzymeslevelatpatientswithtype2diabetesmellitus
AT ascicbuturovicbelma metabolicsyndromeandserumliverenzymeslevelatpatientswithtype2diabetesmellitus
AT tunaenes metabolicsyndromeandserumliverenzymeslevelatpatientswithtype2diabetesmellitus